Title |
Nigella sativa supplementation to treat symptomatic mild COVID-19: A structured summary of a protocol for a randomised, controlled, clinical trial
|
---|---|
Published in |
Trials, August 2020
|
DOI | 10.1186/s13063-020-04647-x |
Pubmed ID | |
Authors |
Abdulrahman E. Koshak, Emad A. Koshak, Abdullah F. Mobeireek, Mazen A. Badawi, Siraj O. Wali, Husam M. Malibary, Ali F. Atwah, Meshari M. Alhamdan, Reem A. Almalki, Tariq A. Madani |
X Demographics
The data shown below were collected from the profiles of 92 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
Country | Count | As % |
---|---|---|
Saudi Arabia | 28 | 30% |
Turkey | 3 | 3% |
United Kingdom | 3 | 3% |
Kuwait | 2 | 2% |
Oman | 1 | 1% |
Australia | 1 | 1% |
Palestine, State of | 1 | 1% |
United States | 1 | 1% |
United Arab Emirates | 1 | 1% |
Other | 1 | 1% |
Unknown | 50 | 54% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 74 | 80% |
Scientists | 12 | 13% |
Practitioners (doctors, other healthcare professionals) | 6 | 7% |
Mendeley readers
The data shown below were compiled from readership statistics for 275 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 275 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Bachelor | 35 | 13% |
Student > Master | 26 | 9% |
Researcher | 23 | 8% |
Student > Ph. D. Student | 18 | 7% |
Other | 14 | 5% |
Other | 44 | 16% |
Unknown | 115 | 42% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 55 | 20% |
Nursing and Health Professions | 29 | 11% |
Pharmacology, Toxicology and Pharmaceutical Science | 15 | 5% |
Biochemistry, Genetics and Molecular Biology | 7 | 3% |
Psychology | 6 | 2% |
Other | 34 | 12% |
Unknown | 129 | 47% |